FdaApplication

NDA 219839

Back to search

Identifiers

Properties

PropertyValue
applicant_nameDIZAL PHARMACEUTICAL CO LTD
application_typeNDA
approval_date2025-07-02

Products (2)

ProductActive ingredientStrengthDosage form
ZEGFROVYSUNVOZERTINIB150MGTABLET;ORAL
ZEGFROVYSUNVOZERTINIB200MGTABLET;ORAL

2 products